Company Amarillo Biosciences, Inc. Other OTC
Equities
AMAR
US02301P2056
Biotechnology & Medical Research
Business Summary
Sales per Business
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Point-of-care Testing
100.0
%
| 4 | 100.0 % | 0 | 100.0 % | -96.53% |
Sales per region
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
United States
100.0
%
| 4 | 100.0 % | 0 | 100.0 % | -96.53% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Chun Hsien Tsai
CEO | Chief Executive Officer | 54 | 21-04-14 |
Lawrence Lin
COO | Chief Operating Officer | 55 | 21-07-31 |
Shu Ying Pan
SAM | Sales & Marketing | - | - |
Chih-Heng Lu
PRN | Corporate Officer/Principal | 44 | 21-08-10 |
Junyong Lee
LAW | General Counsel | 54 | 21-07-31 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Yao Chung Chiang
BRD | Director/Board Member | 70 | 21-04-14 |
Pao Sheng Wei
BRD | Director/Board Member | 66 | 22-06-14 |
Chung Yi Tsai
BRD | Director/Board Member | 47 | 21-04-14 |
Chung Jung Tsai
BRD | Director/Board Member | 52 | 21-04-14 |
Ting Chuan Lee
BRD | Director/Board Member | 40 | 21-04-14 |
Wen Han Chang
BRD | Director/Board Member | 60 | 21-04-14 |
Chun Hsien Tsai
CEO | Chief Executive Officer | 54 | 21-04-14 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 5,954,317 | 2,696,958 ( 45.29 %) | 0 | 45.29 % |
Company contact information
Sector
1st Jan change | Capi. | |
---|---|---|
-1.65% | 103B | |
+6.75% | 101B | |
+6.70% | 23.07B | |
-12.60% | 22.23B | |
-5.06% | 18.05B | |
-39.98% | 17.18B | |
-10.17% | 16.94B | |
+6.12% | 14.07B | |
+35.47% | 12.35B |